Report Detail

Pharma & Healthcare Global Oral Rotavirus Vaccine Market Insights, Forecast to 2025

  • RnM2428447
  • |
  • 17 April, 2019
  • |
  • Global
  • |
  • 112 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Oral Rotavirus Vaccine Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Oral Rotavirus Vaccine Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Oral Rotavirus Vaccine Market Size Growth Rate by Product
      • 1.4.2 Rotarix
      • 1.4.3 RotaTeq
      • 1.4.4 Rotavac
      • 1.4.5 Rotavin-M1
      • 1.4.6 Lanzhou Lamb
    • 1.5 Market by End User
      • 1.5.1 Global Oral Rotavirus Vaccine Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Vaccination Station
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Oral Rotavirus Vaccine Market Size
      • 2.1.1 Global Oral Rotavirus Vaccine Revenue 2014-2025
      • 2.1.2 Global Oral Rotavirus Vaccine Sales 2014-2025
    • 2.2 Oral Rotavirus Vaccine Growth Rate by Regions
      • 2.2.1 Global Oral Rotavirus Vaccine Sales by Regions
      • 2.2.2 Global Oral Rotavirus Vaccine Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Oral Rotavirus Vaccine Sales by Manufacturers
      • 3.1.1 Oral Rotavirus Vaccine Sales by Manufacturers
      • 3.1.2 Oral Rotavirus Vaccine Sales Market Share by Manufacturers
      • 3.1.3 Global Oral Rotavirus Vaccine Market Concentration Ratio (CR5 and HHI)
    • 3.2 Oral Rotavirus Vaccine Revenue by Manufacturers
      • 3.2.1 Oral Rotavirus Vaccine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Oral Rotavirus Vaccine Revenue Share by Manufacturers (2014-2019)
    • 3.3 Oral Rotavirus Vaccine Price by Manufacturers
    • 3.4 Oral Rotavirus Vaccine Manufacturing Base Distribution, Product Types
      • 3.4.1 Oral Rotavirus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Oral Rotavirus Vaccine Product Type
      • 3.4.3 Date of International Manufacturers Enter into Oral Rotavirus Vaccine Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Oral Rotavirus Vaccine Sales by Product
    • 4.2 Global Oral Rotavirus Vaccine Revenue by Product
    • 4.3 Oral Rotavirus Vaccine Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Oral Rotavirus Vaccine Breakdown Data by End User

    6 North America

    • 6.1 North America Oral Rotavirus Vaccine by Countries
      • 6.1.1 North America Oral Rotavirus Vaccine Sales by Countries
      • 6.1.2 North America Oral Rotavirus Vaccine Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Oral Rotavirus Vaccine by Product
    • 6.3 North America Oral Rotavirus Vaccine by End User

    7 Europe

    • 7.1 Europe Oral Rotavirus Vaccine by Countries
      • 7.1.1 Europe Oral Rotavirus Vaccine Sales by Countries
      • 7.1.2 Europe Oral Rotavirus Vaccine Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Oral Rotavirus Vaccine by Product
    • 7.3 Europe Oral Rotavirus Vaccine by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Oral Rotavirus Vaccine by Countries
      • 8.1.1 Asia Pacific Oral Rotavirus Vaccine Sales by Countries
      • 8.1.2 Asia Pacific Oral Rotavirus Vaccine Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Oral Rotavirus Vaccine by Product
    • 8.3 Asia Pacific Oral Rotavirus Vaccine by End User

    9 Central & South America

    • 9.1 Central & South America Oral Rotavirus Vaccine by Countries
      • 9.1.1 Central & South America Oral Rotavirus Vaccine Sales by Countries
      • 9.1.2 Central & South America Oral Rotavirus Vaccine Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Oral Rotavirus Vaccine by Product
    • 9.3 Central & South America Oral Rotavirus Vaccine by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Oral Rotavirus Vaccine by Countries
      • 10.1.1 Middle East and Africa Oral Rotavirus Vaccine Sales by Countries
      • 10.1.2 Middle East and Africa Oral Rotavirus Vaccine Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Oral Rotavirus Vaccine by Product
    • 10.3 Middle East and Africa Oral Rotavirus Vaccine by End User

    11 Company Profiles

    • 11.1 GSK
      • 11.1.1 GSK Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 GSK Oral Rotavirus Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 GSK Oral Rotavirus Vaccine Products Offered
      • 11.1.5 GSK Recent Development
    • 11.2 Sanofi-Pasteur
      • 11.2.1 Sanofi-Pasteur Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Sanofi-Pasteur Oral Rotavirus Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Sanofi-Pasteur Oral Rotavirus Vaccine Products Offered
      • 11.2.5 Sanofi-Pasteur Recent Development
    • 11.3 Merck
      • 11.3.1 Merck Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Merck Oral Rotavirus Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Merck Oral Rotavirus Vaccine Products Offered
      • 11.3.5 Merck Recent Development
    • 11.4 CSL Biotherapies
      • 11.4.1 CSL Biotherapies Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 CSL Biotherapies Oral Rotavirus Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 CSL Biotherapies Oral Rotavirus Vaccine Products Offered
      • 11.4.5 CSL Biotherapies Recent Development
    • 11.5 LG Life Sciences
      • 11.5.1 LG Life Sciences Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 LG Life Sciences Oral Rotavirus Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 LG Life Sciences Oral Rotavirus Vaccine Products Offered
      • 11.5.5 LG Life Sciences Recent Development
    • 11.6 Crucell
      • 11.6.1 Crucell Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Crucell Oral Rotavirus Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Crucell Oral Rotavirus Vaccine Products Offered
      • 11.6.5 Crucell Recent Development
    • 11.7 China National Biotec Group
      • 11.7.1 China National Biotec Group Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 China National Biotec Group Oral Rotavirus Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 China National Biotec Group Oral Rotavirus Vaccine Products Offered
      • 11.7.5 China National Biotec Group Recent Development
    • 11.8 Hualan Biological Engineering
      • 11.8.1 Hualan Biological Engineering Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Hualan Biological Engineering Oral Rotavirus Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Hualan Biological Engineering Oral Rotavirus Vaccine Products Offered
      • 11.8.5 Hualan Biological Engineering Recent Development
    • 11.9 Sinovac Biotech
      • 11.9.1 Sinovac Biotech Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Sinovac Biotech Oral Rotavirus Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Sinovac Biotech Oral Rotavirus Vaccine Products Offered
      • 11.9.5 Sinovac Biotech Recent Development
    • 11.10 Dalian Hissen Bio-pharm
      • 11.10.1 Dalian Hissen Bio-pharm Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Dalian Hissen Bio-pharm Oral Rotavirus Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Dalian Hissen Bio-pharm Oral Rotavirus Vaccine Products Offered
      • 11.10.5 Dalian Hissen Bio-pharm Recent Development

    12 Future Forecast

    • 12.1 Oral Rotavirus Vaccine Market Forecast by Regions
      • 12.1.1 Global Oral Rotavirus Vaccine Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Oral Rotavirus Vaccine Revenue Forecast by Regions 2019-2025
    • 12.2 Oral Rotavirus Vaccine Market Forecast by Product
      • 12.2.1 Global Oral Rotavirus Vaccine Sales Forecast by Product 2019-2025
      • 12.2.2 Global Oral Rotavirus Vaccine Revenue Forecast by Product 2019-2025
    • 12.3 Oral Rotavirus Vaccine Market Forecast by End User
    • 12.4 North America Oral Rotavirus Vaccine Forecast
    • 12.5 Europe Oral Rotavirus Vaccine Forecast
    • 12.6 Asia Pacific Oral Rotavirus Vaccine Forecast
    • 12.7 Central & South America Oral Rotavirus Vaccine Forecast
    • 12.8 Middle East and Africa Oral Rotavirus Vaccine Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Oral Rotavirus Vaccine Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Oral Rotavirus Vaccine market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oral Rotavirus Vaccine market based on company, product type, end user and key regions.

      This report studies the global market size of Oral Rotavirus Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oral Rotavirus Vaccine in these regions.
      This research report categorizes the global Oral Rotavirus Vaccine market by top players/brands, region, type and end user. This report also studies the global Oral Rotavirus Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      GSK
      Sanofi-Pasteur
      Merck
      CSL Biotherapies
      LG Life Sciences
      Crucell
      China National Biotec Group
      Hualan Biological Engineering
      Sinovac Biotech
      Dalian Hissen Bio-pharm

      Market size by Product
      Rotarix
      RotaTeq
      Rotavac
      Rotavin-M1
      Lanzhou Lamb
      Market size by End User
      Hospital
      Vaccination Station
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Oral Rotavirus Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Oral Rotavirus Vaccine market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Oral Rotavirus Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Oral Rotavirus Vaccine submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Oral Rotavirus Vaccine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oral Rotavirus Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Oral Rotavirus Vaccine . Industry analysis & Market Report on Oral Rotavirus Vaccine is a syndicated market report, published as Global Oral Rotavirus Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Oral Rotavirus Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,063.19
      4,594.79
      6,126.39
      3,428.31
      5,142.47
      6,856.62
      418,852.20
      628,278.30
      837,704.40
      270,911.94
      406,367.91
      541,823.88
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report